Clinical Trials Browser

Active not recruiting × Waldenstrom Macroglobulinemia × venetoclax × Clear all

NCT04273139 2025-07-30

Ibrutinib + Venetoclax in Untreated WM

Phase 2 Active not recruiting

45 enrolled 15 charts

Waldenstrom Macroglobulinemia